Literature DB >> 21998478

Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.

Judith E Mueller1, Seydou Yaro, Berthe-Marie Njanpop-Lafourcade, Aly Drabo, Régina S Idohou, Sita S Kroman, Oumarou Sanou, Serge Diagbouga, Yves Traoré, Lassana Sangaré, Raymond Borrow, Bradford D Gessner.   

Abstract

BACKGROUND: To better understand localized meningococcal meningitis epidemics, we evaluated a serogroup A (NmA) epidemic in Burkina Faso by surveillance, carriage, and seroprevalence studies.
METHODS: During March-April 2006, cerebrospinal fluid samples from patients suspected to have meningitis in 3 epidemic villages were analyzed by culture or polymerase chain reaction. We assessed meningococcal carriage and serogroup-specific serum bactericidal antibody titers with baby rabbit complement (rSBA) in a representative population sample (N = 624; age range, 1-39 years). A serogroup A/C polysaccharide vaccine campaign occurred in parallel.
RESULTS: Cumulative incidence of Nm meningitis was 0.45% and varied among villages (0.08%-0.91%). NmA carriage prevalence was 16% without variation by vaccination status. NmA carriage and anti-NmA seroprevalence varied by village and incidence. In the 2 villages with highest incidence and seroprevalence, presence of rSBA titers ≥8 was associated with NmA carriage (odds ratio [OR], 9.33 [95% confidence interval {CI}, 1.90-45.91]) and vaccination ≤4 days earlier (OR, 0.10 [95% CI, .03-.32]). Visibly purulent or Nm meningitis was significantly associated with recent flulike symptoms and exposure to kitchen smoke (risk ratios >15).
CONCLUSIONS: A surge of NmA carriage may be involved in the development of meningococcal epidemics and rapidly increase anti-NmA seroprevalence. Flulike infection and kitchen smoke may contribute to the strength of epidemics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998478      PMCID: PMC3247801          DOI: 10.1093/infdis/jir623

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  [CEREBROSPINAL MENINGITIS IN AFRICA].

Authors:  L LAPEYSSONNIE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

2.  The development of a MUAC-for-height reference, including a comparison to other nutritional status screening indicators.

Authors:  Z Mei; L M Grummer-Strawn; M de Onis; R Yip
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 3.  Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Authors:  Judith E Mueller; Raymond Borrow; Bradford D Gessner
Journal:  Expert Rev Vaccines       Date:  2006-06       Impact factor: 5.217

4.  Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.

Authors:  Isabelle Parent du Châtelet; Yves Traore; Bradford D Gessner; Aude Antignac; B Naccro; Berthe-Marie Njanpop-Lafourcade; Macaire S Ouedraogo; Sylvestre R Tiendrebeogo; Emmanuelle Varon; Muhammed K Taha
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

5.  Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Authors:  S E Maslanka; L L Gheesling; D E Libutti; K B Donaldson; H S Harakeh; J K Dykes; F F Arhin; S J Devi; C E Frasch; J C Huang; P Kriz-Kuzemenska; R D Lemmon; M Lorange; C C Peeters; S Quataert; J Y Tai; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.

Authors:  C D Marchant; E Band; J E Froeschle; P H McVerry
Journal:  Pediatr Infect Dis J       Date:  1989-08       Impact factor: 2.129

7.  Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates.

Authors:  D V Madore; C L Johnson-Kraines; E P Rothstein; D H Smith
Journal:  Curr Med Res Opin       Date:  1999       Impact factor: 2.580

8.  Risk factors for meningococcal meningitis in northern Ghana.

Authors:  A Hodgson; T Smith; S Gagneux; M Adjuik; G Pluschke; N K Mensah; F Binka; B Genton
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Sep-Oct       Impact factor: 2.184

9.  Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.

Authors:  Judith E Mueller; Seydou Yaro; Yves Traore; Lassana Sangare; Zekiba Tarnagda; Berthe-Marie Njanpop-Lafourcade; Raymond Borrow; Bradford D Gessner
Journal:  J Infect Dis       Date:  2006-02-08       Impact factor: 5.226

10.  Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso.

Authors:  Isabelle Delrieu; Seydou Yaro; Tsidi A S Tamekloé; Berthe-Marie Njanpop-Lafourcade; Haoua Tall; Philippe Jaillard; Macaire S Ouedraogo; Kossi Badziklou; Oumarou Sanou; Aly Drabo; Bradford D Gessner; Jean L Kambou; Judith E Mueller
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

View more
  15 in total

1.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

2.  Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.

Authors:  Haoua Tall; Stéphane Hugonnet; Philippe Donnen; Michèle Dramaix-Wilmet; Ludovic Kambou; Frank Drabo; Judith E Mueller
Journal:  BMC Infect Dis       Date:  2012-01-05       Impact factor: 3.090

3.  The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.

Authors: 
Journal:  J Infect Dis       Date:  2015-04-09       Impact factor: 5.226

4.  Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger.

Authors:  Halima Boubacar Maïnassara; Juliette Paireau; Issa Idi; Jean-Paul Moulia Pelat; Odile Ouwe Missi Oukem-Boyer; Arnaud Fontanet; Judith E Mueller
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

5.  Knowledge of obstetric fistula prevention amongst young women in urban and rural Burkina Faso: a cross-sectional study.

Authors:  Aduragbemi O Banke-Thomas; Salam F Kouraogo; Aboubacar Siribie; Henock B Taddese; Judith E Mueller
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 6.  Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis.

Authors:  Thibaut Koutangni; Halima Boubacar Maïnassara; Judith E Mueller
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

7.  A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

Authors:  Olivier Manigart; Caroline Trotter; Helen Findlow; Abraham Assefa; Wude Mihret; Tesfaye Moti Demisse; Biruk Yeshitela; Isaac Osei; Abraham Hodgson; Stephen Laryea Quaye; Samba Sow; Mamadou Coulibaly; Kanny Diallo; Awa Traore; Jean-Marc Collard; Rahamatou Moustapha Boukary; Oumarou Djermakoye; Ali Elhaji Mahamane; Jean-François Jusot; Cheikh Sokhna; Serge Alavo; Souleymane Doucoure; El Hadj Ba; Mariétou Dieng; Aldiouma Diallo; Doumagoum Moto Daugla; Babatunji Omotara; Daniel Chandramohan; Musa Hassan-King; Maria Nascimento; Arouna Woukeu; Ray Borrow; James M Stuart; Brian Greenwood
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

8.  Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.

Authors:  Caroline L Trotter; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Sita S Kroman; Regina S Idohou; Oumarou Sanou; Leah Bowen; Helen Findlow; Serge Diagbouga; Bradford D Gessner; Ray Borrow; Judith E Mueller
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

9.  A multi-state spatio-temporal Markov model for categorized incidence of meningitis in sub-Saharan Africa.

Authors:  L Agier; M Stanton; G Soga; P J Diggle
Journal:  Epidemiol Infect       Date:  2012-09-21       Impact factor: 4.434

10.  Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt.

Authors:  Andromachi Karachaliou; Andrew J K Conlan; Marie-Pierre Preziosi; Caroline L Trotter
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.